Combined PARP14 inhibition and PD-1 blockade promotes cytotoxic T cell quiescence and modulates macrophage polarization in relapsed melanoma
Background Programmed cell death 1 (PD-1) signaling blockade by immune checkpoint inhibitors (ICI) effectively restores immune surveillance to treat melanoma. However, chronic interferon-gamma (IFNγ)-induced immune homeostatic responses in melanoma cells contribute to immune evasion and acquired res...
Saved in:
Main Authors: | Chun Wai Wong, Rotem Leshem, Kieran Neil Sefton, I-Hsuan Lin, Dervla Tamara Isaac, Mario Niepel, Adam Hurlstone |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/13/1/e010683.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV
by: Diwakar Davar, et al.
Published: (2015-01-01) -
PD-1 Checkpoint Blockade in Patients for Acute Myeloid Leukemia after HSCT Relapse Resulted in Severe GVHD and sHLH
by: Zhi zhuo Du, et al.
Published: (2022-01-01) -
Immune Checkpoint Blockade in Melanoma – Earlier is Better?
by: Vincas Urbonas, et al.
Published: (2024-09-01) -
p130 And pRb in the Maintenance of Transient Quiescence of Mesenchymal Stem Cells
by: Boris Popov, et al.
Published: (2020-01-01) -
PARP4 deficiency enhances sensitivity to ATM inhibitor by impairing DNA damage repair in melanoma
by: Yuehua Li, et al.
Published: (2025-01-01)